Study of TDM-180935 in Atopic Dermatitis Patients

NCT06363461 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis

Interventions

DRUG: TDM-180935 topical ointment 1.0%
DRUG: TDM-180935 topical ointment 2.0%
DRUG: TDM-180935 topical vehicle ointment 1
DRUG: TDM-180935 topical vehicle ointment 2

Sponsor

Technoderma Medicines Inc.

Collaborators

[object Object]